Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion

by Michael D. Kim, Nathalie Baumlin, John S. Dennis, Makoto Yoshida, Adrian Kis, Carolina Aguiar, Andreas Schmid, Eliana Mendes, Matthias Salathe
Published 2021-01-01

An Open Label Trial to Assess Safety of Losartan for Treating Worsening Respiratory Illness in COVID-19

by Charles D. Bengtson, Robert N. Montgomery, Robert N. Montgomery, Usman Nazir, Lewis Satterwhite, Michael D. Kim, Nathan C. Bahr, Mario Castro, Nathalie Baumlin, Matthias Salathe
Published 2021-02-01